CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study

Go back to CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
(NASDAQ: CNTG) Delayed: 0.33 --0 (-0%)
Previous Close $0.33    52 Week High
Open $0.33    52 Week Low
Day High $0.33    P/E N/A 
Day Low $0.33    EPS
Volume 7,175